PGEN · Company research
Precigen, Inc. Common Stock (PGEN): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 7.54 | $3,230,894,415.65 | 3214565415.65 | 156.2000000000000000 | — | — | 58.7670416466586635 | 74.1438960815586561 | — |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.